← All trials
NCT04403334
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 2, 2018
- Primary completion
- Apr 28, 2018
- Completion date
- Apr 28, 2018
- First posted
- May 27, 2020
- Last posted
- May 27, 2020
- Enrollment
- 114
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Peregrine Eye and Laser InstituteLead sponsor
- Peregrine Eye and Laser InstituteReponsible party - principal investigator
- Peregrine Eye and Laser InstituteOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.